Taiho Pharmaceutical Co., Ltd.,

Taiho Pharmaceutical Co., Ltd. is a subsidiary of Otsuka Holdings Co., Ltd. that focuses on oncology, allergy and immunology, and urology. Established in 1963, the company is renowned for developing innovative cancer treatments and expanding its global presence through extensive R&D. Its corporate philosophy centers around striving to improve human health and contribute to a society enriched by smiles. Apart from oncology, Taiho Pharmaceutical also creates high-quality products for various medical conditions to enhance people's quality of life. The company is committed to prioritizing customer needs and aims to offer consumer healthcare products that support fulfilling and rewarding lives. As a specialist in R&D-driven specialty pharma, Taiho Pharmaceutical presents promising opportunities for investors seeking to contribute to the advancement of human health and well-being.